Cabrera, Jorge Rubén
Rodríguez-Izquierdo, Ignacio
Jiménez, José Luis
Muñoz-Fernández, María Ángeles http://orcid.org/0000-0002-0813-4500
Funding for this research was provided by:
Instituto de Salud Carlos III (RD16/0025/0019; RETIC PT17/0015/0042; PI16/01863; PI19/01638; CIBER-BBN, PI17/01115)
Comunidad de Madrid (B2017/BMD-3703)
Uniwersytet Łódzki (NAWA International Academic Partnership Programme)
European Cooperation in Science and Technology (COST Action CA 17140 "Cancer Nanomedicine from the Bench to the Bedside")
PENTA FOUNDATION (EPIICAL Project)
IiSGM (Intramural COV20/MAM-BIS)
Article History
Received: 10 February 2020
Accepted: 25 November 2020
First Online: 7 December 2020
Ethics approval and consent to participate
: Animal studies were conducted and approved by the CBMSO Institutional Animal Care and Use Committee (CEEA-CBMSO, Madrid, Spain). All experiments were carried out following CEEA-CBMSO, National (Royal Decree 1201/2005), and the Directive 2010/63/EU of the European Parliament guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.